TL02-59 is a potent and selective small-molecule inhibitor of the Src-family kinase Fgr (IC50 = 0.03 nM), with additional activity against Lyn and Hck. It demonstrates potent anti-proliferative effects in acute myelogenous leukemia (AML) cell cultures, supporting its use as a research tool for studying kinase signaling in hematological malignancies.
